Protein Summary
- ENST00000401979
- ENSP00000384880
- ENSG00000153310
- ENST00000517654
- ENSP00000430674
- ENST00000519110
- ENSP00000429078
- ENST00000519540
- ENSP00000429499
- ENST00000519824
- ENSP00000429150
- ENST00000522250
- ENSP00000429978
- ENST00000522746
- ENSP00000428117
- ENST00000522941
- ENSP00000430433
- ENST00000523509
- ENSP00000429802
- L1
- BM-009
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
disease perturbation | 0.97 | ||
transcription factor binding site profile | 0.92 | ||
histone modification site profile | 0.89 | ||
kinase perturbation | 0.84 | ||
transcription factor perturbation | 0.84 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 73.13 (req: < 5)
Gene RIFs: 10 (req: <= 3)
Antibodies: 72 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 73.13 (req: >= 5)
Gene RIFs: 10 (req: > 3)
Antibodies: 72 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 6
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0